ClinVar Miner

Submissions for variant NM_000455.4(STK11):c.1127A>C (p.Glu376Ala) (rs373888280)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000115594 SCV000184985 uncertain significance Hereditary cancer-predisposing syndrome 2017-02-15 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence,In silico models in agreement (benign)
Color RCV000115594 SCV000686590 uncertain significance Hereditary cancer-predisposing syndrome 2018-10-17 criteria provided, single submitter clinical testing
Counsyl RCV000205503 SCV000785631 uncertain significance Peutz-Jeghers syndrome 2017-10-17 criteria provided, single submitter clinical testing
GeneDx RCV000586344 SCV000149503 uncertain significance not provided 2018-09-11 criteria provided, single submitter clinical testing This variant is denoted STK11 c.1127A>C at the cDNA level, p.Glu376Ala (E376A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAG>GCG). This variant has not, to our knowledge, been published in the literature as a pathogenic or benign germline variant. STK11 Glu376Ala was not observed at a significant allele frequency in large population cohorts (Lek 2016). STK11 Glu376Ala is not located in a known functional domain. In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether STK11 Glu376Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Integrated Genetics/Laboratory Corporation of America RCV000586344 SCV000696702 uncertain significance not provided 2017-05-22 criteria provided, single submitter clinical testing Variant summary: The STK11 c.1127A>C (p.Glu376Ala) variant causes a missense change involving the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 3/96906 control chromosomes at a frequency of 0.000031, which is approximately 5 times the estimated maximal expected allele frequency of a pathogenic STK11 variant (0.0000063), suggesting this variant is likely a benign polymorphism. Multiple clinical diagnostic laboratories/reputable databases classified this variant as uncertain significance. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as VUS until additional information is obtained.
Invitae RCV000205503 SCV000260042 uncertain significance Peutz-Jeghers syndrome 2018-07-17 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid with alanine at codon 376 of the STK11 protein (p.Glu376Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs373888280, ExAC 0.03%). This variant has not been reported in the literature in individuals with STK11-related disease. ClinVar contains an entry for this variant (Variation ID: 127698). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.